nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—NR0B1—Dexamethasone—ankylosing spondylitis	0.291	0.398	CbGbCtD
Tretinoin—CYP4A11—Dexamethasone—ankylosing spondylitis	0.14	0.191	CbGbCtD
Tretinoin—CYP2A6—Prednisolone—ankylosing spondylitis	0.0506	0.0692	CbGbCtD
Tretinoin—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0306	0.0419	CbGbCtD
Tretinoin—CYP2A6—Dexamethasone—ankylosing spondylitis	0.0298	0.0408	CbGbCtD
Tretinoin—CYP1A1—Dexamethasone—ankylosing spondylitis	0.0255	0.0348	CbGbCtD
Tretinoin—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0204	0.0279	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0204	0.0279	CbGbCtD
Tretinoin—CYP2B6—Dexamethasone—ankylosing spondylitis	0.0194	0.0265	CbGbCtD
Tretinoin—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0158	0.0216	CbGbCtD
Tretinoin—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0153	0.0209	CbGbCtD
Tretinoin—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0147	0.0201	CbGbCtD
Tretinoin—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0119	0.0163	CbGbCtD
Tretinoin—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0103	0.014	CbGbCtD
Tretinoin—CYP3A4—Betamethasone—ankylosing spondylitis	0.0102	0.014	CbGbCtD
Tretinoin—CYP3A4—Prednisolone—ankylosing spondylitis	0.0101	0.0138	CbGbCtD
Tretinoin—CYP3A4—Prednisone—ankylosing spondylitis	0.00955	0.0131	CbGbCtD
Tretinoin—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00596	0.00815	CbGbCtD
Tretinoin—Sweating—Methotrexate—ankylosing spondylitis	0.000127	0.000471	CcSEcCtD
Tretinoin—Infection—Methylprednisolone—ankylosing spondylitis	0.000127	0.000471	CcSEcCtD
Tretinoin—Haematuria—Methotrexate—ankylosing spondylitis	0.000126	0.000469	CcSEcCtD
Tretinoin—Shock—Triamcinolone—ankylosing spondylitis	0.000126	0.000467	CcSEcCtD
Tretinoin—Insomnia—Prednisolone—ankylosing spondylitis	0.000126	0.000467	CcSEcCtD
Tretinoin—Alopecia—Prednisone—ankylosing spondylitis	0.000125	0.000467	CcSEcCtD
Tretinoin—Shock—Methylprednisolone—ankylosing spondylitis	0.000125	0.000466	CcSEcCtD
Tretinoin—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000125	0.000465	CcSEcCtD
Tretinoin—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000125	0.000464	CcSEcCtD
Tretinoin—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000125	0.000464	CcSEcCtD
Tretinoin—Epistaxis—Methotrexate—ankylosing spondylitis	0.000125	0.000464	CcSEcCtD
Tretinoin—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000125	0.000464	CcSEcCtD
Tretinoin—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000125	0.000463	CcSEcCtD
Tretinoin—Mental disorder—Prednisone—ankylosing spondylitis	0.000124	0.000463	CcSEcCtD
Tretinoin—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000124	0.000462	CcSEcCtD
Tretinoin—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000124	0.00046	CcSEcCtD
Tretinoin—Erythema—Prednisone—ankylosing spondylitis	0.000124	0.00046	CcSEcCtD
Tretinoin—Malnutrition—Prednisone—ankylosing spondylitis	0.000124	0.00046	CcSEcCtD
Tretinoin—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000123	0.000459	CcSEcCtD
Tretinoin—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000123	0.000459	CcSEcCtD
Tretinoin—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000123	0.000458	CcSEcCtD
Tretinoin—Convulsion—Dexamethasone—ankylosing spondylitis	0.000123	0.000457	CcSEcCtD
Tretinoin—Convulsion—Betamethasone—ankylosing spondylitis	0.000123	0.000457	CcSEcCtD
Tretinoin—Hypertension—Dexamethasone—ankylosing spondylitis	0.000123	0.000456	CcSEcCtD
Tretinoin—Hypertension—Betamethasone—ankylosing spondylitis	0.000123	0.000456	CcSEcCtD
Tretinoin—Myalgia—Betamethasone—ankylosing spondylitis	0.000121	0.000449	CcSEcCtD
Tretinoin—Myalgia—Dexamethasone—ankylosing spondylitis	0.000121	0.000449	CcSEcCtD
Tretinoin—Anxiety—Betamethasone—ankylosing spondylitis	0.00012	0.000448	CcSEcCtD
Tretinoin—Anxiety—Dexamethasone—ankylosing spondylitis	0.00012	0.000448	CcSEcCtD
Tretinoin—Discomfort—Dexamethasone—ankylosing spondylitis	0.000119	0.000444	CcSEcCtD
Tretinoin—Discomfort—Betamethasone—ankylosing spondylitis	0.000119	0.000444	CcSEcCtD
Tretinoin—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000119	0.000444	CcSEcCtD
Tretinoin—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000119	0.000443	CcSEcCtD
Tretinoin—Pain—Prednisolone—ankylosing spondylitis	0.000119	0.000442	CcSEcCtD
Tretinoin—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000119	0.000441	CcSEcCtD
Tretinoin—Hepatitis—Methotrexate—ankylosing spondylitis	0.000119	0.000441	CcSEcCtD
Tretinoin—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000118	0.000438	CcSEcCtD
Tretinoin—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000117	0.000436	CcSEcCtD
Tretinoin—Vision blurred—Prednisone—ankylosing spondylitis	0.000116	0.000433	CcSEcCtD
Tretinoin—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000116	0.000433	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000116	0.000433	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000116	0.000432	CcSEcCtD
Tretinoin—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000116	0.000431	CcSEcCtD
Tretinoin—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000116	0.000431	CcSEcCtD
Tretinoin—Oedema—Dexamethasone—ankylosing spondylitis	0.000116	0.000431	CcSEcCtD
Tretinoin—Oedema—Betamethasone—ankylosing spondylitis	0.000116	0.000431	CcSEcCtD
Tretinoin—Insomnia—Triamcinolone—ankylosing spondylitis	0.000115	0.000429	CcSEcCtD
Tretinoin—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000115	0.000429	CcSEcCtD
Tretinoin—Infection—Betamethasone—ankylosing spondylitis	0.000115	0.000428	CcSEcCtD
Tretinoin—Infection—Dexamethasone—ankylosing spondylitis	0.000115	0.000428	CcSEcCtD
Tretinoin—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000115	0.000427	CcSEcCtD
Tretinoin—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000115	0.000426	CcSEcCtD
Tretinoin—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000114	0.000426	CcSEcCtD
Tretinoin—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000114	0.000425	CcSEcCtD
Tretinoin—Visual impairment—Methotrexate—ankylosing spondylitis	0.000114	0.000425	CcSEcCtD
Tretinoin—Anaemia—Prednisone—ankylosing spondylitis	0.000114	0.000425	CcSEcCtD
Tretinoin—Shock—Dexamethasone—ankylosing spondylitis	0.000114	0.000424	CcSEcCtD
Tretinoin—Shock—Betamethasone—ankylosing spondylitis	0.000114	0.000424	CcSEcCtD
Tretinoin—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000114	0.000423	CcSEcCtD
Tretinoin—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000114	0.000423	CcSEcCtD
Tretinoin—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000114	0.000423	CcSEcCtD
Tretinoin—Agitation—Prednisone—ankylosing spondylitis	0.000114	0.000423	CcSEcCtD
Tretinoin—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000113	0.000422	CcSEcCtD
Tretinoin—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000113	0.000422	CcSEcCtD
Tretinoin—Tachycardia—Betamethasone—ankylosing spondylitis	0.000113	0.000421	CcSEcCtD
Tretinoin—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000113	0.000421	CcSEcCtD
Tretinoin—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000112	0.000418	CcSEcCtD
Tretinoin—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000112	0.000417	CcSEcCtD
Tretinoin—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000112	0.000417	CcSEcCtD
Tretinoin—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000112	0.000417	CcSEcCtD
Tretinoin—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000112	0.000417	CcSEcCtD
Tretinoin—Malaise—Prednisone—ankylosing spondylitis	0.000111	0.000415	CcSEcCtD
Tretinoin—Eye disorder—Methotrexate—ankylosing spondylitis	0.000111	0.000412	CcSEcCtD
Tretinoin—Syncope—Prednisone—ankylosing spondylitis	0.000111	0.000412	CcSEcCtD
Tretinoin—Tinnitus—Methotrexate—ankylosing spondylitis	0.000111	0.000412	CcSEcCtD
Tretinoin—Anorexia—Dexamethasone—ankylosing spondylitis	0.00011	0.000411	CcSEcCtD
Tretinoin—Anorexia—Betamethasone—ankylosing spondylitis	0.00011	0.000411	CcSEcCtD
Tretinoin—Urticaria—Prednisolone—ankylosing spondylitis	0.00011	0.00041	CcSEcCtD
Tretinoin—Fatigue—Triamcinolone—ankylosing spondylitis	0.00011	0.000409	CcSEcCtD
Tretinoin—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00011	0.000408	CcSEcCtD
Tretinoin—Pain—Triamcinolone—ankylosing spondylitis	0.000109	0.000406	CcSEcCtD
Tretinoin—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000109	0.000404	CcSEcCtD
Tretinoin—Hypotension—Betamethasone—ankylosing spondylitis	0.000108	0.000403	CcSEcCtD
Tretinoin—Hypotension—Dexamethasone—ankylosing spondylitis	0.000108	0.000403	CcSEcCtD
Tretinoin—Angiopathy—Methotrexate—ankylosing spondylitis	0.000108	0.0004	CcSEcCtD
Tretinoin—Convulsion—Prednisone—ankylosing spondylitis	0.000107	0.000398	CcSEcCtD
Tretinoin—Hypertension—Prednisone—ankylosing spondylitis	0.000107	0.000397	CcSEcCtD
Tretinoin—Chills—Methotrexate—ankylosing spondylitis	0.000106	0.000396	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000106	0.000393	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000106	0.000393	CcSEcCtD
Tretinoin—Myalgia—Prednisone—ankylosing spondylitis	0.000105	0.000391	CcSEcCtD
Tretinoin—Arthralgia—Prednisone—ankylosing spondylitis	0.000105	0.000391	CcSEcCtD
Tretinoin—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000105	0.000391	CcSEcCtD
Tretinoin—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000105	0.00039	CcSEcCtD
Tretinoin—Anxiety—Prednisone—ankylosing spondylitis	0.000105	0.00039	CcSEcCtD
Tretinoin—Alopecia—Methotrexate—ankylosing spondylitis	0.000105	0.00039	CcSEcCtD
Tretinoin—Insomnia—Betamethasone—ankylosing spondylitis	0.000105	0.00039	CcSEcCtD
Tretinoin—Insomnia—Dexamethasone—ankylosing spondylitis	0.000105	0.00039	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000105	0.000389	CcSEcCtD
Tretinoin—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000104	0.000387	CcSEcCtD
Tretinoin—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000104	0.000387	CcSEcCtD
Tretinoin—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000104	0.000387	CcSEcCtD
Tretinoin—Discomfort—Prednisone—ankylosing spondylitis	0.000104	0.000387	CcSEcCtD
Tretinoin—Mental disorder—Methotrexate—ankylosing spondylitis	0.000104	0.000387	CcSEcCtD
Tretinoin—Erythema—Methotrexate—ankylosing spondylitis	0.000103	0.000384	CcSEcCtD
Tretinoin—Malnutrition—Methotrexate—ankylosing spondylitis	0.000103	0.000384	CcSEcCtD
Tretinoin—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000102	0.00038	CcSEcCtD
Tretinoin—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000102	0.000379	CcSEcCtD
Tretinoin—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000102	0.000379	CcSEcCtD
Tretinoin—Urticaria—Triamcinolone—ankylosing spondylitis	0.000101	0.000377	CcSEcCtD
Tretinoin—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000101	0.000376	CcSEcCtD
Tretinoin—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000101	0.000375	CcSEcCtD
Tretinoin—Oedema—Prednisone—ankylosing spondylitis	0.000101	0.000375	CcSEcCtD
Tretinoin—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000101	0.000375	CcSEcCtD
Tretinoin—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000101	0.000375	CcSEcCtD
Tretinoin—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000101	0.000375	CcSEcCtD
Tretinoin—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000101	0.000375	CcSEcCtD
Tretinoin—Infection—Prednisone—ankylosing spondylitis	0.0001	0.000373	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.0001	0.000372	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.0001	0.000372	CcSEcCtD
Tretinoin—Back pain—Methotrexate—ankylosing spondylitis	9.99e-05	0.000372	CcSEcCtD
Tretinoin—Fatigue—Betamethasone—ankylosing spondylitis	9.99e-05	0.000371	CcSEcCtD
Tretinoin—Fatigue—Dexamethasone—ankylosing spondylitis	9.99e-05	0.000371	CcSEcCtD
Tretinoin—Shock—Prednisone—ankylosing spondylitis	9.92e-05	0.000369	CcSEcCtD
Tretinoin—Pain—Dexamethasone—ankylosing spondylitis	9.91e-05	0.000368	CcSEcCtD
Tretinoin—Pain—Betamethasone—ankylosing spondylitis	9.91e-05	0.000368	CcSEcCtD
Tretinoin—Nervous system disorder—Prednisone—ankylosing spondylitis	9.89e-05	0.000368	CcSEcCtD
Tretinoin—Tachycardia—Prednisone—ankylosing spondylitis	9.85e-05	0.000366	CcSEcCtD
Tretinoin—Skin disorder—Prednisone—ankylosing spondylitis	9.8e-05	0.000364	CcSEcCtD
Tretinoin—Hyperhidrosis—Prednisone—ankylosing spondylitis	9.75e-05	0.000363	CcSEcCtD
Tretinoin—Vision blurred—Methotrexate—ankylosing spondylitis	9.74e-05	0.000362	CcSEcCtD
Tretinoin—Anorexia—Prednisone—ankylosing spondylitis	9.62e-05	0.000358	CcSEcCtD
Tretinoin—Ill-defined disorder—Methotrexate—ankylosing spondylitis	9.58e-05	0.000357	CcSEcCtD
Tretinoin—Anaemia—Methotrexate—ankylosing spondylitis	9.55e-05	0.000355	CcSEcCtD
Tretinoin—Feeling abnormal—Dexamethasone—ankylosing spondylitis	9.55e-05	0.000355	CcSEcCtD
Tretinoin—Feeling abnormal—Betamethasone—ankylosing spondylitis	9.55e-05	0.000355	CcSEcCtD
Tretinoin—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	9.47e-05	0.000352	CcSEcCtD
Tretinoin—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	9.47e-05	0.000352	CcSEcCtD
Tretinoin—Hypersensitivity—Triamcinolone—ankylosing spondylitis	9.41e-05	0.00035	CcSEcCtD
Tretinoin—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	9.38e-05	0.000349	CcSEcCtD
Tretinoin—Malaise—Methotrexate—ankylosing spondylitis	9.32e-05	0.000347	CcSEcCtD
Tretinoin—Urticaria—Dexamethasone—ankylosing spondylitis	9.2e-05	0.000342	CcSEcCtD
Tretinoin—Urticaria—Betamethasone—ankylosing spondylitis	9.2e-05	0.000342	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	9.19e-05	0.000342	CcSEcCtD
Tretinoin—Dizziness—Prednisolone—ankylosing spondylitis	9.18e-05	0.000341	CcSEcCtD
Tretinoin—Asthenia—Triamcinolone—ankylosing spondylitis	9.16e-05	0.000341	CcSEcCtD
Tretinoin—Body temperature increased—Dexamethasone—ankylosing spondylitis	9.16e-05	0.000341	CcSEcCtD
Tretinoin—Abdominal pain—Dexamethasone—ankylosing spondylitis	9.16e-05	0.000341	CcSEcCtD
Tretinoin—Abdominal pain—Betamethasone—ankylosing spondylitis	9.16e-05	0.000341	CcSEcCtD
Tretinoin—Body temperature increased—Betamethasone—ankylosing spondylitis	9.16e-05	0.000341	CcSEcCtD
Tretinoin—Asthenia—Methylprednisolone—ankylosing spondylitis	9.14e-05	0.00034	CcSEcCtD
Tretinoin—Insomnia—Prednisone—ankylosing spondylitis	9.12e-05	0.000339	CcSEcCtD
Tretinoin—Paraesthesia—Prednisone—ankylosing spondylitis	9.06e-05	0.000337	CcSEcCtD
Tretinoin—Pruritus—Triamcinolone—ankylosing spondylitis	9.03e-05	0.000336	CcSEcCtD
Tretinoin—Cough—Methotrexate—ankylosing spondylitis	9.01e-05	0.000335	CcSEcCtD
Tretinoin—Pruritus—Methylprednisolone—ankylosing spondylitis	9.01e-05	0.000335	CcSEcCtD
Tretinoin—Convulsion—Methotrexate—ankylosing spondylitis	8.95e-05	0.000333	CcSEcCtD
Tretinoin—Dyspepsia—Prednisone—ankylosing spondylitis	8.88e-05	0.00033	CcSEcCtD
Tretinoin—Chest pain—Methotrexate—ankylosing spondylitis	8.79e-05	0.000327	CcSEcCtD
Tretinoin—Myalgia—Methotrexate—ankylosing spondylitis	8.79e-05	0.000327	CcSEcCtD
Tretinoin—Arthralgia—Methotrexate—ankylosing spondylitis	8.79e-05	0.000327	CcSEcCtD
Tretinoin—Decreased appetite—Prednisone—ankylosing spondylitis	8.77e-05	0.000326	CcSEcCtD
Tretinoin—Rash—Prednisolone—ankylosing spondylitis	8.75e-05	0.000326	CcSEcCtD
Tretinoin—Dermatitis—Prednisolone—ankylosing spondylitis	8.74e-05	0.000325	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	8.73e-05	0.000325	CcSEcCtD
Tretinoin—Diarrhoea—Methylprednisolone—ankylosing spondylitis	8.72e-05	0.000324	CcSEcCtD
Tretinoin—Fatigue—Prednisone—ankylosing spondylitis	8.7e-05	0.000324	CcSEcCtD
Tretinoin—Headache—Prednisolone—ankylosing spondylitis	8.7e-05	0.000323	CcSEcCtD
Tretinoin—Discomfort—Methotrexate—ankylosing spondylitis	8.69e-05	0.000323	CcSEcCtD
Tretinoin—Constipation—Prednisone—ankylosing spondylitis	8.63e-05	0.000321	CcSEcCtD
Tretinoin—Confusional state—Methotrexate—ankylosing spondylitis	8.5e-05	0.000316	CcSEcCtD
Tretinoin—Dizziness—Triamcinolone—ankylosing spondylitis	8.44e-05	0.000314	CcSEcCtD
Tretinoin—Anaphylactic shock—Methotrexate—ankylosing spondylitis	8.43e-05	0.000314	CcSEcCtD
Tretinoin—Dizziness—Methylprednisolone—ankylosing spondylitis	8.42e-05	0.000313	CcSEcCtD
Tretinoin—Infection—Methotrexate—ankylosing spondylitis	8.38e-05	0.000312	CcSEcCtD
Tretinoin—Feeling abnormal—Prednisone—ankylosing spondylitis	8.31e-05	0.000309	CcSEcCtD
Tretinoin—Asthenia—Dexamethasone—ankylosing spondylitis	8.31e-05	0.000309	CcSEcCtD
Tretinoin—Asthenia—Betamethasone—ankylosing spondylitis	8.31e-05	0.000309	CcSEcCtD
Tretinoin—Nervous system disorder—Methotrexate—ankylosing spondylitis	8.27e-05	0.000308	CcSEcCtD
Tretinoin—Thrombocytopenia—Methotrexate—ankylosing spondylitis	8.25e-05	0.000307	CcSEcCtD
Tretinoin—Gastrointestinal pain—Prednisone—ankylosing spondylitis	8.25e-05	0.000307	CcSEcCtD
Tretinoin—Nausea—Prednisolone—ankylosing spondylitis	8.25e-05	0.000307	CcSEcCtD
Tretinoin—Pruritus—Betamethasone—ankylosing spondylitis	8.2e-05	0.000305	CcSEcCtD
Tretinoin—Pruritus—Dexamethasone—ankylosing spondylitis	8.2e-05	0.000305	CcSEcCtD
Tretinoin—Skin disorder—Methotrexate—ankylosing spondylitis	8.19e-05	0.000305	CcSEcCtD
Tretinoin—Hyperhidrosis—Methotrexate—ankylosing spondylitis	8.15e-05	0.000303	CcSEcCtD
Tretinoin—Vomiting—Triamcinolone—ankylosing spondylitis	8.12e-05	0.000302	CcSEcCtD
Tretinoin—Vomiting—Methylprednisolone—ankylosing spondylitis	8.1e-05	0.000301	CcSEcCtD
Tretinoin—Rash—Triamcinolone—ankylosing spondylitis	8.05e-05	0.000299	CcSEcCtD
Tretinoin—Dermatitis—Triamcinolone—ankylosing spondylitis	8.04e-05	0.000299	CcSEcCtD
Tretinoin—Anorexia—Methotrexate—ankylosing spondylitis	8.04e-05	0.000299	CcSEcCtD
Tretinoin—Rash—Methylprednisolone—ankylosing spondylitis	8.03e-05	0.000299	CcSEcCtD
Tretinoin—Dermatitis—Methylprednisolone—ankylosing spondylitis	8.02e-05	0.000298	CcSEcCtD
Tretinoin—Urticaria—Prednisone—ankylosing spondylitis	8.01e-05	0.000298	CcSEcCtD
Tretinoin—Headache—Triamcinolone—ankylosing spondylitis	8e-05	0.000297	CcSEcCtD
Tretinoin—Headache—Methylprednisolone—ankylosing spondylitis	7.98e-05	0.000297	CcSEcCtD
Tretinoin—Abdominal pain—Prednisone—ankylosing spondylitis	7.97e-05	0.000297	CcSEcCtD
Tretinoin—Body temperature increased—Prednisone—ankylosing spondylitis	7.97e-05	0.000297	CcSEcCtD
Tretinoin—Diarrhoea—Betamethasone—ankylosing spondylitis	7.93e-05	0.000295	CcSEcCtD
Tretinoin—Diarrhoea—Dexamethasone—ankylosing spondylitis	7.93e-05	0.000295	CcSEcCtD
Tretinoin—Hypotension—Methotrexate—ankylosing spondylitis	7.88e-05	0.000293	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	7.68e-05	0.000286	CcSEcCtD
Tretinoin—Dizziness—Betamethasone—ankylosing spondylitis	7.66e-05	0.000285	CcSEcCtD
Tretinoin—Dizziness—Dexamethasone—ankylosing spondylitis	7.66e-05	0.000285	CcSEcCtD
Tretinoin—Insomnia—Methotrexate—ankylosing spondylitis	7.63e-05	0.000284	CcSEcCtD
Tretinoin—Nausea—Triamcinolone—ankylosing spondylitis	7.58e-05	0.000282	CcSEcCtD
Tretinoin—Paraesthesia—Methotrexate—ankylosing spondylitis	7.57e-05	0.000282	CcSEcCtD
Tretinoin—Nausea—Methylprednisolone—ankylosing spondylitis	7.57e-05	0.000281	CcSEcCtD
Tretinoin—Dyspnoea—Methotrexate—ankylosing spondylitis	7.52e-05	0.00028	CcSEcCtD
Tretinoin—Somnolence—Methotrexate—ankylosing spondylitis	7.49e-05	0.000279	CcSEcCtD
Tretinoin—Hypersensitivity—Prednisone—ankylosing spondylitis	7.43e-05	0.000276	CcSEcCtD
Tretinoin—Dyspepsia—Methotrexate—ankylosing spondylitis	7.42e-05	0.000276	CcSEcCtD
Tretinoin—Vomiting—Dexamethasone—ankylosing spondylitis	7.36e-05	0.000274	CcSEcCtD
Tretinoin—Vomiting—Betamethasone—ankylosing spondylitis	7.36e-05	0.000274	CcSEcCtD
Tretinoin—Decreased appetite—Methotrexate—ankylosing spondylitis	7.33e-05	0.000273	CcSEcCtD
Tretinoin—Rash—Betamethasone—ankylosing spondylitis	7.3e-05	0.000272	CcSEcCtD
Tretinoin—Rash—Dexamethasone—ankylosing spondylitis	7.3e-05	0.000272	CcSEcCtD
Tretinoin—Dermatitis—Dexamethasone—ankylosing spondylitis	7.3e-05	0.000271	CcSEcCtD
Tretinoin—Dermatitis—Betamethasone—ankylosing spondylitis	7.3e-05	0.000271	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	7.28e-05	0.000271	CcSEcCtD
Tretinoin—Fatigue—Methotrexate—ankylosing spondylitis	7.27e-05	0.00027	CcSEcCtD
Tretinoin—Headache—Dexamethasone—ankylosing spondylitis	7.26e-05	0.00027	CcSEcCtD
Tretinoin—Headache—Betamethasone—ankylosing spondylitis	7.26e-05	0.00027	CcSEcCtD
Tretinoin—Asthenia—Prednisone—ankylosing spondylitis	7.24e-05	0.000269	CcSEcCtD
Tretinoin—Pain—Methotrexate—ankylosing spondylitis	7.21e-05	0.000268	CcSEcCtD
Tretinoin—Pruritus—Prednisone—ankylosing spondylitis	7.14e-05	0.000265	CcSEcCtD
Tretinoin—Feeling abnormal—Methotrexate—ankylosing spondylitis	6.95e-05	0.000258	CcSEcCtD
Tretinoin—Diarrhoea—Prednisone—ankylosing spondylitis	6.9e-05	0.000257	CcSEcCtD
Tretinoin—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	6.89e-05	0.000256	CcSEcCtD
Tretinoin—Nausea—Betamethasone—ankylosing spondylitis	6.88e-05	0.000256	CcSEcCtD
Tretinoin—Nausea—Dexamethasone—ankylosing spondylitis	6.88e-05	0.000256	CcSEcCtD
Tretinoin—Urticaria—Methotrexate—ankylosing spondylitis	6.7e-05	0.000249	CcSEcCtD
Tretinoin—Dizziness—Prednisone—ankylosing spondylitis	6.67e-05	0.000248	CcSEcCtD
Tretinoin—Abdominal pain—Methotrexate—ankylosing spondylitis	6.66e-05	0.000248	CcSEcCtD
Tretinoin—Body temperature increased—Methotrexate—ankylosing spondylitis	6.66e-05	0.000248	CcSEcCtD
Tretinoin—Vomiting—Prednisone—ankylosing spondylitis	6.41e-05	0.000239	CcSEcCtD
Tretinoin—Rash—Prednisone—ankylosing spondylitis	6.36e-05	0.000237	CcSEcCtD
Tretinoin—Dermatitis—Prednisone—ankylosing spondylitis	6.35e-05	0.000236	CcSEcCtD
Tretinoin—Headache—Prednisone—ankylosing spondylitis	6.32e-05	0.000235	CcSEcCtD
Tretinoin—Hypersensitivity—Methotrexate—ankylosing spondylitis	6.21e-05	0.000231	CcSEcCtD
Tretinoin—Asthenia—Methotrexate—ankylosing spondylitis	6.05e-05	0.000225	CcSEcCtD
Tretinoin—Nausea—Prednisone—ankylosing spondylitis	5.99e-05	0.000223	CcSEcCtD
Tretinoin—Pruritus—Methotrexate—ankylosing spondylitis	5.96e-05	0.000222	CcSEcCtD
Tretinoin—Diarrhoea—Methotrexate—ankylosing spondylitis	5.77e-05	0.000215	CcSEcCtD
Tretinoin—Dizziness—Methotrexate—ankylosing spondylitis	5.57e-05	0.000207	CcSEcCtD
Tretinoin—Vomiting—Methotrexate—ankylosing spondylitis	5.36e-05	0.000199	CcSEcCtD
Tretinoin—Rash—Methotrexate—ankylosing spondylitis	5.32e-05	0.000198	CcSEcCtD
Tretinoin—Dermatitis—Methotrexate—ankylosing spondylitis	5.31e-05	0.000198	CcSEcCtD
Tretinoin—Headache—Methotrexate—ankylosing spondylitis	5.28e-05	0.000196	CcSEcCtD
Tretinoin—Nausea—Methotrexate—ankylosing spondylitis	5.01e-05	0.000186	CcSEcCtD
